Retraction: Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo (International Journal of Oncology (2013) 43 (1281-1290) DOI: 10.3892/ijo.2013.2046);Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo

International Journal of Oncology

Volumn 43, Issue 4, 2013, Pages 1281-1290

  Tang, Bo ^a   Li, Yang ^b   Yuan, Shengguang ^a   Tomlinson, Stephen ^c   He, Songqing ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b Medical Oncology   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Hepatocellular carcinoma; Progress; opioid receptor

Indexed keywords

DELTA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TUMOR GROWTH; TUMOR INVASION;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; NEOPLASM INVASIVENESS; RECEPTORS, OPIOID, DELTA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84882436846     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2023.5504     Document Type: Erratum

References (37)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Rampone B, Schiavone B, Martino A, Viviano C and Confuorto G: Current management strategy of hepatocellular carcinoma. World J Gastroenterol 15: 3210-3216, 2009.
3. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW and Weitz J: Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253: 453-469, 2011.
4. Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y and Miao Y: Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World J Surg Oncol 10: 163, 2012.
5. DuBray BJ Jr, Chapman WC and Anderson CD: Hepatocellular carcinoma: a review of the surgical approaches to management. Mo Med 108: 195-198, 2011.
6. Salhab M and Canelo R: An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther 7: 463-475, 2011.
7. Law PY, Wong YH and Loh HH: Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389-430, 2000.
8. Kieffer BL, Befort K, Gaveriaux-Ruff C and Hirth CG: The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89: 12048-12052, 1992.
9. Evans CJ, Keith DE Jr, Morrison H, Magendzo K and Edwards RH: Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955, 1992.
10. Bzdega T, Chin H, Kim H, Jung HH, Kozak CA and Klee WA: Regional expression and chromosomal localization of the delta opiate receptor gene. Proc Natl Acad Sci USA 90: 9305-9309, 1993.
11. Simonin F, Befort K, Gavériaux-Ruff C, Matthes H, Nappey V, Lannes B, Micheletti G and Kieffer B: The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol Pharmacol 46: 1015-1021, 1994.
12. Madar I, Bencherif B, Lever J, Heitmiller RF, Yang SC, Brock M, Brahmer J, Ravert H, Dannals R and Frost JJ: Imaging delta-and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med 48: 207-213, 2007.
13. Zagon IS, McLaughlin PJ, Goodman SR and Rhodes RE: Opioid receptors and endogenous opioids in diverse human and animal cancers. J Natl Cancer Inst 79: 1059-1065, 1987.
14. Bostwick DG, Null WE, Holmes D, Weber E, Barchas JD and Bensch KG: Expression of opioid peptides in tumors. N Engl J Med 317: 1439-1443, 1987.
15. Lundberg JM, Hamberger B, Schultzberg M, Hökfelt T, Granberg PO, Efendi S, Terenius L, Goldstein M and Luft R: Enkephalin-and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci USA 76: 4079-4083, 1979.
16. Heiss A, Ammer H and Eisinger DA: delta-opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation. Exp Cell Res 315: 2115-2125, 2009.
17. Debruyne D, Leroy A, DE Wever O, Vakaet L, Mareel M and Bracke M: Direct effects of delta opioid receptor agonists on invasion-associated activities of HCT-8/E11 colon cancer cells. Anticancer Res 30: 9-17, 2010.
18. Nicoll J, Axiotis CA and Bergasa NV: The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses 65: 1099-1105, 2005.
19. Bergasa NV and Boyella VD: Liver derived endogenous opioids may interfere with the therapeutic effect of interferon in chronic hepatitis C. Med Hypotheses 70: 556-559, 2008.
20. De Minicis S, Candelaresi C, Marzioni M, Saccomano S, Roskams T, Casini A, Risaliti A, Salzano R, Cautero N, di Francesco F, Benedetti A and Svegliati-Baroni G: Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. Gut 57: 352-364, 2008.
21. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H and Wang L: Activation of the opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med 28: 1077-1085, 2011.
22. Zhang B, Zhang X, Tang B, Zheng P and Zhang Y: Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor (ER) re-expression. Breast Cancer Res Treat 136: 399-406, 2012.
23. Alvira-Botero MX and Garzón M: Cellular and subcellular distributions of delta opioid receptor activation sites in the ventral oral pontine tegmentum of the cat. Brain Res 1123: 101-111, 2006.
24. Wang HB, Guan JS, Bao L and Zhang X: Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells. Neurochem Res 33: 2028-2034, 2008.
25. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, Maldonado R and Kieffer BL: Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152: 1238-1248, 2011.
26. Howells RD, Kilpatrick DL, Bailey LC, Noe M and Udenfriend S: Proenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 83: 1960-1963, 1986.
27. Neidle A, Manigault I and Wajda IJ: Distribution of opiate-like substances in rat tissues. Neurochem Res 4: 399-410, 1979.
28. Wittert G, Hope P and Pyle D: Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 218: 877-881, 1996.
29. Kilpatrick DL, Howells RD, Noe M, Bailey LC and Udenfriend S: Expression of preproenkephalin-like mRNA and its peptide products in mammalian testis and ovary. Proc Natl Acad Sci USA 82: 7467-7469, 1985.
30. Civelli O, Douglass J, Goldstein A and Herbert E: Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82: 4291-4295, 1985.
31. Radulovi J and Jankovi BD: Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat. Brain Res 661: 189-195, 1994.
32. Su TP: Delta opioid peptide[D-Ala(2),D-Leu(5)]enkephalin promotes cell survival. J Biomed Sci 7: 195-199, 2000.
33. Kim H, Lee SW, Park JS, Min JH and Kim HK: Genomic analysis of [d-Ala(2), d-Leu(5)] enkephalin preconditioning in cortical neuron and glial cell injury after oxygen deprivation. Brain Res 1447: 91-105, 2012.
34. Marzioni M, Alpini G, Saccomanno S, de Minicis S, Glaser S, Francis H, Trozzi L, Venter J, Orlando F, Fava G, Candelaresi C, Macarri G and Benedetti A: Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 130: 1831-1847, 2006.
35. Kuniyasu H, Luo Y, Fujii K, Sasahira T, Moriwaka Y, Tatsumoto N, Sasaki T, Yamashita Y and Ohmori H: CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver. Gut 59: 348-356, 2010.
36. Hatzoglou A, Kampa M and Castanas E: Opioid-somatostatin interactions in regulating cancer cell growth. Front Biosci 10: 244-256, 2005.
37. Zhou XD: Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int 1: 35-41, 2002.